Antithrombotic therapy post-TAVI suboptimal: Aus study

More evidence is needed on real-world outcomes for use of prophylactic drugs to better guide practice, researchers say

One in three Australians undergoing transcatheter aortic valve implantation miss out on guideline-recommended antithrombotic therapy post-discharge, a study shows.

Sydney researchers say local rates of antithrombotic use following the procedure appear to be lower than those reported internationally, with significant room for improvement.